Evaluation of the effect of early BCG-vaccination on development of asthma and allergic rhinitis during childhood - follow-up study at age 7 years.

Evaluation of the effect of early BCG-vaccination on development of asthma and allergic rhinitis during childhood - follow-up study at age 7 years. - Follow-up study on BCG vaccination and atopy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36994

Enrollment

116

Registered

2008-05-20

Start date

2008-10-05

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma hayfever

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: participation in study with code WOK 98-24, dd 01-02-1999

Exclusion criteria

Exclusion criteria: no participation in earlier study with code WOK 98-24

Design outcomes

Primary

Measure	Time frame
Asthma, defined by periodic wheezing and dyspnoea, combined with a 9% reversibility in FEV1 and/or exhaled NO above 20 ppb. Allergic rhinitis. defined by periodic or perennial sneezing, runny or blocked nose when not having a cold or the flu.	—

Secondary

Measure	Time frame
Nitric oxide measurements in nasal air, specific IgE to allergens and immunologic parameters in serum.	—

Countries

Netherlands

Outcome results